Literature DB >> 11906960

Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels.

Yu Huang1, Franky Leung Chan, Chi-Wai Lau, Suk-Ying Tsang, Guo-Wei He, Zhen-Yu Chen, Xiaoqiang Yao.   

Abstract

1. The mechanisms underlying the vasodilator response to urocortin are incompletely understood. The present study was designed to examine the role of endothelial nitric oxide and Ba(2+)-sensitive K(+) channels in the endothelium-dependent component of urocortin-induced relaxation in the rat left anterior descending coronary artery. 2. Urocortin induced both endothelium-dependent and -independent relaxation with respective pD(2) of 8.64+/-0.03 and 7.90+/-0.10. Removal of endothelium reduced the relaxing potency of urocortin. In rings pretreated with 10(-4) M N(G)-nitro-L-arginine methyl ester, 10(-5) M methylene blue or 10(-5) M ODQ, the urocortin-induced relaxation was similar to that observed in endothelium-denuded rings. L-Arginine (5x10(-4) M) antagonized the effect of N(G)-nitro-L-arginine methyl ester. 3. The relaxant response to urocortin was reduced in endothelium-intact rings preconstricted by 3.5x10(-2) M K(+) and abolished when extracellular K(+) was raised to 5x10(-2) M. Pretreatment with 10(-4) M BaCl(2) significantly inhibited urocortin-induced relaxation. Combined treatment with 10(-4) M BaCl(2) plus 10(-4) M N(G)-nitro-L-arginine methyl ester did not cause further inhibition. In urocortin (10(-8) M)-relaxed rings, BaCl(2) induced concentration-dependent reversal in vessel tone. Tertiapin-Q (10(-6) M) also attenuated urocortin-induced relaxation. In contrast, BaCl(2) did not alter urocortin-induced relaxation in endothelium-denuded rings. 4. In endothelium-denuded rings, hydroxylamine- and nitroprusside-induced relaxation was inhibited by 10(-4) M BaCl(2), but not by 10(-6) M tertiapin-Q. 5. The endothelium of the coronary artery was moderately stained with the antiserum against urocortin. 6. Taken together, the present results indicate that the urocortin-induced endothelium-dependent relaxation of rat coronary arteries is likely attributable to endothelial nitric oxide and subsequent activation of Ba(2+)- or tertiapin-Q-sensitive K(+) channels. The urocortin-induced endothelium-dependent relaxation appears to be mediated by cyclic GMP-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906960      PMCID: PMC1573252          DOI: 10.1038/sj.bjp.0704587

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Mechanisms of inward-rectifier K+ channel inhibition by tertiapin-Q.

Authors:  W Jin; A M Klem; J H Lewis; Z Lu
Journal:  Biochemistry       Date:  1999-10-26       Impact factor: 3.162

2.  Tertiapin potently and selectively blocks muscarinic K(+) channels in rabbit cardiac myocytes.

Authors:  H Kitamura; M Yokoyama; H Akita; K Matsushita; Y Kurachi; M Yamada
Journal:  J Pharmacol Exp Ther       Date:  2000-04       Impact factor: 4.030

3.  Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart.

Authors:  T Nishikimi; A Miyata; T Horio; F Yoshihara; N Nagaya; S Takishita; C Yutani; H Matsuo; H Matsuoka; K Kangawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

4.  Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart.

Authors:  K Terui; A Higashiyama; N Horiba; K I Furukawa; S Motomura; T Suda
Journal:  J Endocrinol       Date:  2001-04       Impact factor: 4.286

5.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

6.  Urocortin hyperpolarizes stomach smooth muscle via activation of Ca2+-sensitive K+ currents.

Authors:  P S Petkova-Kirova; H S Gagov; D B Duridanova
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

7.  Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway.

Authors:  B K Brar; A K Jonassen; A Stephanou; G Santilli; J Railson; R A Knight; D M Yellon; D S Latchman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

8.  The properties of the inward rectifier potassium currents in rabbit coronary arterial smooth muscle cells.

Authors:  X Xu; S J Rials; Y Wu; R A Marinchak; P R Kowey
Journal:  Pflugers Arch       Date:  1999-07       Impact factor: 3.657

9.  Sauvagine, a new polypeptide from Phyllomedusa sauvagei skin. Occurrence in various Phyllomedusa species and pharmacological actions on rat blood pressure and diuresis.

Authors:  V Erspamer; G F Erspamer; G Improta; L Negri; R de Castiglione
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-07       Impact factor: 3.000

10.  Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

Authors:  D Pearson; J E Shively; B R Clark; I I Geschwind; M Barkley; R S Nishioka; H A Bern
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more
  14 in total

1.  Evaluation of Serum Urocortin 2 Levels in Patients with Hypertension.

Authors:  Gamze Aslan; Saide Aytekin
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-01-10

2.  Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts.

Authors:  Angel Luis García-Villalón; Yesika María Amezquita; Luis Monge; Nuria Fernández; Belén Climent; Ana Sánchez; Godofredo Diéguez
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Mechanisms of relaxation by urocortin in renal arteries from male and female rats.

Authors:  Elena Sanz; Luis Monge; Nuria Fernández; Belén Climent; Godofredo Diéguez; Angel Luis Garcia-Villalón
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

4.  CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.

Authors:  Katherine E Wiley; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

5.  Urocortin ameliorates diabetic nephropathy in obese db/db mice.

Authors:  X Li; J Hu; R Zhang; X Sun; Q Zhang; X Guan; J Chen; Q Zhu; S Li
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

6.  Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney.

Authors:  Carmen M Troncoso Brindeiro; Rachel W Fallet; Pascale H Lane; Pamela K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-21

7.  Urocortin 2 stimulates nitric oxide production in ventricular myocytes via Akt- and PKA-mediated phosphorylation of eNOS at serine 1177.

Authors:  Stefanie Walther; Florentina Pluteanu; Susanne Renz; Yulia Nikonova; Joshua T Maxwell; Li-Zhen Yang; Kurt Schmidt; Joshua N Edwards; Paulina Wakula; Klaus Groschner; Lars S Maier; Joachim Spiess; Lothar A Blatter; Burkert Pieske; Jens Kockskämper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

8.  Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation.

Authors:  Zhengrong Hao; Yan Huang; Jake Cleman; Ion S Jovin; Wylie W Vale; Tracy L Bale; Frank J Giordano
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

9.  Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta 1 and VEGF.

Authors:  Xuan Li; Jue Hu; Qichun Zhang; Xiaoyu Sun; Shengnan Li
Journal:  Br J Pharmacol       Date:  2009-05-18       Impact factor: 8.739

10.  Vascular effects of urocortins 2 and 3 in healthy volunteers.

Authors:  Sowmya Venkatasubramanian; Megan E Griffiths; Steven G McLean; Mark R Miller; Rosa Luo; Ninian N Lang; David E Newby
Journal:  J Am Heart Assoc       Date:  2013-01-31       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.